Pharma Reviews: 'Limited immediate risk from Covid-19 to India pharma sector'

Mumbai: The immediate risk to the Indian pharma industry from the supply shortages of key raw materials from China due to coronavirus outbreak is ...
Read more: 'Limited immediate risk from Covid-19 to India pharma sector'